검색어 : 통합검색[Washington Kerry]
총 1,024건 중 1,000건 출력
, 100/100 페이지
-
991
- ABSTRACTS
- Bagliacca, Marco; Valentini, Alessio; Cappuccio, I.; Schroeder, Michael A.; Bland, James D.; Kumpu, Paavo; Helle, Pekka; Nikula, Ari; Crawford, John A.; Thirgood, Simon J.; Redpath, Stephen M.; Franceschi, Paolo F.; Sepulcri, Angela; Filacorda, Stefano; Piasentier, Edi; Storch, Ilse; Dimmick, Ralph W.; Sole, Jeffrey D.; Hale, Phillip E.; Minser, William G.; Miller, Richard F.; Eddleman, Lee L.; Doan, Melora A.; Dimmick, Ralph W.; Buehler, David A.; Rennie, John C.; Pelren, Eric C.; Crawford, John A.; Higgins, Laura A.; Hill, Jennifer A.; Young, Jessica R.; Howard, Richard D.; Morrow, Michael E.; Griffin, Clifton P.; Peterson, Markus J.; Silvy, Nova J.; Young, Jessica R.; Minchella, Dennis J.; Weiss, Helmut; Mé noni, Emmanuel; Landry, Philippe; Berducou, C.; Baba, Yoshiyuki; Koike, Hiroko; Okayama, Toshinao; Fujimaki, Yuzou; Westerberg, Anne E.; Apa, Anthony D.; Reese, Kerry P.; Connelly Jr., John W.; Willebrand, Tomas; Smith, A.; Departmento di Produzione AnimaleUniversità di Pisa, Via delle PiaggePisaItaly; Istituto di Zootecnia, Università della TusciaVia de Lellis ViterboItaly; Istituto di Zootecnia, Università della TusciaVia de Lellis ViterboItaly; Washington Department of Fish and WildlifeBridgeportWashington98813USA; 604 E. 11th StreetDavisCalifornia95616USA; Meltaus Game Research Station, Finnish Game and Fisheries Research InstituteFIN‐ 97340MeltausFinland; Meltaus Game Research Station, Finnish Game and Fisheries Research InstituteFIN‐ 97340MeltausFinland; Finnish Forest Research Institute, Rovaniemi Research StationFIN‐ 96301RovaniemiFinland; Department of Fisheries and WildlifeOregon State UniversityCorvallisOregon97331USA; The Game Conservancy Trust, Crubenmore LodgeNewtonmoreInverness‐ shire, ScotlandPH20 1BEUnited Kingdom; Institute of Terrestrial Ecology, Monks Wood, Abbots RiptonHuntingdonCambridgeshirePE17 2LSUnited Kingdom; Museo Civico; (Wildlife biology, v.3, 1997, pp.269-296)
-
992
- Concentration of H, Si, Cl, K, Fe, and Th in the low‐ and mid‐latitude regions of Mars
- Boynton, W. V.; Taylor, G. J.; Evans, L. G.; Reedy, R. C.; Starr, R.; Janes, D. M.; Kerry, K. E.; Drake, D. M.; Kim, K. J.; Williams, R. M. S.; Crombie, M. K.; Dohm, J. M.; Baker, V.; Metzger, A. E.; Karunatillake, S.; Keller, J. M.; Newsom, H. E.; Arnold, J. R.; Brü ckner, J.; Englert, P. A. J.; Gasnault, O.; Sprague, A. L.; Mitrofanov, I.; Squyres, S. W.; Trombka, J. I.; d'Uston, L.; Wä nke, H.; Hamara, D. K.; Lunar and Planetary Laboratory University of Arizona Tucson Arizona USA; Institute of Geophysics and Planetology University of Hawaii at Manoa Honolulu Hawaii USA; Science Programs Computer Sciences Corporation Lanham Maryland USA; Institute of Meteoritics University of New Mexico Albuquerque New Mexico USA; Department of Physics Catholic University of America Washington D. C. USA; Lunar and Planetary Laboratory University of Arizona Tucson Arizona USA; Lunar and Planetary Laboratory University of Arizona Tucson Arizona USA; TechSource Santa Fe New Mexico USA; Lunar and Planetary Laboratory University of Arizona Tucson Arizona USA; Lunar and Planetary Laboratory University of Arizona Tucson Arizona USA; Lunar and Planetary Laboratory University of Arizona Tucson Arizona USA; Department of Hydrology and Water Resources University of Arizona Tucson Arizona USA; Department of Hydrology and Water Resources University of Arizona Tucson Arizona USA; Jet Propulsion Laboratory Cal; (Journal of geophysical research : JGR. E : Planets, v.112, 2007, pp.2007JE002887)
-
993
- Oral Abstract: TCL-150: The ECHELON-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma
- Iyer, Swaminathan; Trü mper, Lorenz; O’Connor, Owen A.; Pro, Barbara; Illidge, Tim; Advani, Ranjana; Bartlett, Nancy L.; Christensen, Jacob Haaber; Morschhauser, Franck; Domingo-Domenech, Eva; Rossi, Giuseppe; Kim, Won Seog; Feldman, Tatyana; Menne, Tobias; Belada, David; Illè s, Á rpá d; Tobinai, Kensei; Tsukasaki, Kunihiro; Yeh, Su-Peng; Shustov, Andrei; Hü ttmann, Andreas; Savage, Kerry J.; Yuen, Sam; Zinzani, Pier Luigi; Miao, Harry; Bunn, Veronica; Fenton, Keenan; Fanale, Michelle; Puhlmann, Markus; Horwitz, Steven; MD Anderson Cancer Center/University of Texas; Universitä tsmedizin Gö ttingen; E. Couric Cancer Center, University of Virginia; Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, NIHR Biomedical Research Centre, Manchester Academic Health Sciences Centre, Christie Hospital NHS Foundation Trust; Stanford Cancer Center, Blood and Marrow Transplant Program; Washington University School of Medicine; Odense University Hospital; CHRU de Lille; Institut Catala D’oncologia, L’Hospitalet de Llobregat; Azienda Ospedaliera Spedali Civili di Brescia; Samsu; (Clinical lymphoma, myeloma & leukemia, v.21, 2021, pp.S203-S203)
-
994
- Comparison of Prolonged Exposure vs Cognitive Processing Therapy for Treatment of Posttraumatic Stress Disorder Among US Veterans A Randomized Clinical Trial
- Schnurr, Paula P.; Chard, Kathleen M.; Ruzek, Josef I.; Chow, Bruce K.; Resick, Patricia A.; Foa, Edna B.; Marx, Brian P.; Friedman, Matthew J.; Bovin, Michelle J.; Caudle, Kristina L.; Castillo, Diane; Curry, Kyle T.; Hollifield, Michael; Huang, Grant D.; Chee, Christine L.; Astin, Millie C.; Dickstein, Benjamin; Renner, Kerry; Clancy, Carolina P.; Collie, Claire; Maieritsch, Kelly; Bailey, Su; Thompson, Karin; Messina, Michael; Franklin, Laurel; Lindley, Steve; Kattar, Karen; Luedtke, Brandi; Romesser, Jennifer; McQuaid, John; Sylvers, Patrick; Varkovitzky, Ruth; Davis, Lori; MacVicar, David; Shih, Mei-Chiung; VA Cooperative Studies Program Coordinating Center, Palo Alto, California; Duke Health, Durham, North Carolina; University of Pennsylvania Perelman School of Medicine, Department of Psychiatry, Philadelphia; Executive Division, National Center for PTSD, White River Junction, Vermont; Center of Excellence, Central Texas VA Health Care System, Waco; Minneapolis VA Medical Center, Minneapolis, Minnesota; Cooperative Studies Program Central Office, Department of Veterans Affairs Office of Research & Development, Washington, District of Columbia; Raymond G. Murphy VA Medical Center, Albuquerque, New Mexico; Atlanta VA Medical Center, Atlanta, Georgia; Cincinnati VA Medical Center, Cincinnati, Ohio; VA Northeast Ohio Healthcare System, Cleveland; Durham VA Medical Center, Durham, North Carolina; Durham VA Medical Center, Durham, North Carolina; Edward Hines Jr. VA Hospital, Hines, Illinois; Phoenix VA Medical Center, Phoenix, Arizona; Phoenix VA Medical Center, Phoenix, Arizon; (Jama network open, v.5, 2022, pp.e2136921-e2136921)
-
995
- TCL-150: The ECHELON-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma
- Iyer, Swaminathan; Trü mper, Lorenz; O’Connor, Owen A.; Pro, Barbara; Illidge, Tim; Advani, Ranjana; Bartlett, Nancy L.; Christensen, Jacob Haaber; Morschhauser, Franck; Domingo-Domenech, Eva; Rossi, Giuseppe; Kim, Won Seog; Feldman, Tatyana; Menne, Tobias; Belada, David; Illè s, Á rpá d; Tobinai, Kensei; Tsukasaki, Kunihiro; Yeh, Su-Peng; Shustov, Andrei; Hü ttmann, Andreas; Savage, Kerry J.; Yuen, Sam; Zinzani, Pier Luigi; Miao, Harry; Bunn, Veronica; Fenton, Keenan; Fanale, Michelle; Puhlmann, Markus; Horwitz, Steven; MD Anderson Cancer Center/University of Texas; Universitä tsmedizin Gö ttingen; E. Couric Cancer Center, University of Virginia; Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, NIHR Biomedical Research Centre, Manchester Academic Health Sciences Centre, Christie Hospital NHS Foundation Trust; Stanford Cancer Center, Blood and Marrow Transplant Program; Washington University School of Medicine; Odense University Hospital; CHRU de Lille; Institut Catala D’oncologia, L’Hospitalet de Llobregat; Azienda Ospedaliera Spedali Civili di Brescia; Samsu; (Clinical lymphoma, myeloma & leukemia, v.21, 2021, pp.S411-S411)
-
996
- NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024 : Featured Updates to the NCCN Guidelines
- Abu-Rustum, Nadeem R.; Yashar, Catheryn M.; Arend, Rebecca; Barber, Emma; Bradley, Kristin; Brooks, Rebecca; Campos, Susana M.; Chino, Junzo; Chon, Hye Sook; Crispens, Marta Ann; Damast, Shari; Fisher, Christine M.; Frederick, Peter; Gaffney, David K.; Gaillard, Stephanie; Giuntoli, Robert; Glaser, Scott; Holmes, Jordan; Howitt, Brooke E.; Lea, Jayanthi; Mantia-Smaldone, Gina; Mariani, Andrea; Mutch, David; Nagel, Christa; Nekhlyudov, Larissa; Podoll, Mirna; Rodabaugh, Kerry; Salani, Ritu; Schorge, John; Siedel, Jean; Sisodia, Rachel; Soliman, Pamela; Ueda, Stefanie; Urban, Renata; Wyse, Emily; McMillian, Nicole R.; Aggarwal, Shaili; Espinosa, Sara; Memorial Sloan Kettering Cancer Center; UC San Diego Moores Cancer Center; O’Neal Comprehensive Cancer Center at UAB; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; University of Wisconsin Carbone Cancer Center; UC Davis Comprehensive Cancer Center; Dana-Farber/Brigham and Women’s Cancer Center; Duke Cancer Institute; Moffitt Cancer Center; Vanderbilt-Ingram Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Colorado Cancer Center; Roswell Park Comprehensive Cancer Center; Huntsman Cancer Institute at the University of Utah; Abramson Cancer Center at the University of Pennsylvania; City of Hope National Medical Center; Indiana University Melvin and Bren Simon Comprehensive Cancer Center; Stanford Cancer Institute; UT Southwestern Simmons Comprehensive Cancer Center; Fox Chase Cancer Center; Mayo Clinic Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Me; (Journal of the National Comprehensive Cancer Network : JNCCN, v.21, 2023, pp.1224-1233)
-
997
- Weight management and physical activity throughout the cancer care continuum
- Demark‐ Wahnefried, Wendy; Schmitz, Kathryn H.; Alfano, Catherine M.; Bail, Jennifer R.; Goodwin, Pamela J.; Thomson, Cynthia A.; Bradley, Don W.; Courneya, Kerry S.; Befort, Christie A.; Denlinger, Crystal S.; Ligibel, Jennifer A.; Dietz, William H.; Stolley, Melinda R.; Irwin, Melinda L.; Bamman, Marcas M.; Apovian, Caroline M.; Pinto, Bernardine M.; Wolin, Kathleen Y.; Ballard, Rachel M.; Dannenberg, Andrew J.; Eakin, Elizabeth G.; Longjohn, Matt M.; Raffa, Susan D.; Adams‐ Campbell, Lucile L.; Buzaglo, Joanne S.; Nass, Sharyl J.; Massetti, Greta M.; Balogh, Erin P.; Kraft, Elizabeth S.; Parekh, Anand K.; Sanghavi, Darshak M.; Morris, G. Stephen; Basen‐ Engquist, Karen; Professor of Nutrition Sciences, University of Alabama at Birmingham Birmingham AL; Professor of Public Health Sciences, Penn State College of Medicine Hershey PA; Vice President, Survivorship, American Cancer Society, Inc. Washington DC; Post‐ Doctoral Fellow, Department of Nutrition Sciences University of Alabama at Birmingham Birmingham AL; Professor of Medicine, Mount Sinai Hospital Lunenfeld‐ Tanenbaum Research Institute at the University of Toronto Toronto Ontario Canada; Professor of Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health University of Arizona Tucson AZ; Associate Consulting Professor, Community and Family Medicine, Duke School of Medicine Durham NC; Professor of Physical Education and Recreation, University of Alberta Edmonton Alberta Canada; Associate Professor of Preventive Medicine, University of Kansas Medical Center Kansas City KS; Associate Professor of Hematology/Oncology, Fox Chase Cancer Center Philadelphia PA; ; (CA: A Cancer Journal for Clinicians, v.68, 2018, pp.64-89)
-
998
- Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice
- Dalvie, Neil C.; Rodriguez-Aponte, Sergio A.; Hartwell, Brittany L.; Tostanoski, Lisa H.; Biedermann, Andrew M.; Crowell, Laura E.; Kaur, Kawaljit; Kumru, Ozan S.; Carter, Lauren; Yu, Jingyou; Chang, Aiquan; McMahan, Katherine; Courant, Thomas; Lebas, Celia; Lemnios, Ashley A.; Rodrigues, Kristen A.; Silva, Murillo; Johnston, Ryan S.; Naranjo, Christopher A.; Tracey, Mary Kate; Brady, Joseph R.; Whittaker, Charles A.; Yun, Dongsoo; Brunette, Natalie; Wang, Jing Yang; Walkey, Carl; Fiala, Brooke; Kar, Swagata; Porto, Maciel; Lok, Megan; Andersen, Hanne; Lewis, Mark G.; Love, Kerry R.; Camp, Danielle L.; Silverman, Judith Maxwell; Kleanthous, Harry; Joshi, Sangeeta B.; Volkin, David B.; Dubois, Patrice M.; Collin, Nicolas; King, Neil P.; Barouch, Dan H.; Irvine, Darrell J.; Love, J. Christopher; Department of Chemical Engineering, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139; ; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139; ; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139; ; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115; ; Department of Chemical Engineering, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139; ; Department of Chemical Engineering, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139; ; Department of Pharmaceutical Chemistry, Vaccine Analytics, and Formulation Center, University of Kansas, Lawrence, KS 66047; ; Department of Pharmaceutical Chemistry, Vaccine Analytics, and Formulation Center, University of Kansas, Lawrence, KS 66047; ; Department of Biochemistry, University of Washington, Seattle, WA 98195; ; Center; (Proceedings of the National Academy of Sciences of the United States of America, v.118, 2021, pp.e2106845118-e2106845118)
-
999
- Coupled Air Quality and Boundary-Layer Meteorology in Western U.S. Basins during Winter: Design and Rationale for a Comprehensive Study
- Hallar, A. Gannet; Brown, Steven S.; Crosman, Erik; Barsanti, Kelley C.; Cappa, Christopher D.; Faloona, Ian; Fast, Jerome; Holmes, Heather A.; Horel, John; Lin, John; Middlebrook, Ann; Mitchell, Logan; Murphy, Jennifer; Womack, Caroline C.; Aneja, Viney; Baasandorj, Munkhbayar; Bahreini, Roya; Banta, Robert; Bray, Casey; Brewer, Alan; Caulton, Dana; de Gouw, Joost; De Wekker, Stephan F.J.; Farmer, Delphine K.; Gaston, Cassandra J.; Hoch, Sebastian; Hopkins, Francesca; Karle, Nakul N.; Kelly, James T.; Kelly, Kerry; Lareau, Neil; Lu, Keding; Mauldin, Roy L.; Mallia, Derek V.; Martin, Randal; Mendoza, Daniel L.; Oldroyd, Holly J.; Pichugina, Yelena; Pratt, Kerri A.; Saide, Pablo E.; Silva, Philip J.; Simpson, William; Stephens, Britton B.; Stutz, Jochen; Sullivan, Amy; Department of Atmospheric Sciences, University of Utah, Salt Lake City, Utah; NOAA/Chemical Sciences Laboratory, Boulder, Colorado; Department of Life, Earth, and Environmental Sciences, West Texas A&M University, Canyon, Texas; Department of Chemical and Environmental Engineering, Center for Environmental Research and Technology, University of California, Riverside, Riverside, California; Department of Civil and Environmental Engineering, University of California, Davis, Davis, California; Department of Land, Air and Water Resources, University of California, Davis, Davis, California; Atmospheric Science and Global Change Division, Pacific Northwest National Laboratory, Richland, Washington; Department of Chemical Engineering, University of Utah, Salt Lake City, Utah; Department of Atmospheric Sciences, University of Utah, Salt Lake City, Utah; Department of Atmospheric Sciences, University of Utah, Salt Lake City, Utah; NOAA/Chemical Sciences Laboratory, Boulder, Colorado; (Bulletin of the American Meteorological Society, v.102, 2021, pp.E2012-E2033)
-
1000
- The Echelon-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma
- Horwitz, Steven M.; O'Connor, Owen A.; Pro, Barbara; Illidge, Tim; Iyer, Swami P.; Advani, Ranjana; Bartlett, Nancy L.; Christensen, Jacob Haaber; Morschhauser, Franck; Domingo-Domenech, Eva; Rossi, Giuseppe; Kim, Won Seog; Feldman, Tatyana A.; Menne, Tobias; Belada, David; Illé s, Á rpá d; Tobinai, Kensei; Tsukasaki, Kunihiro; Yeh, Su-Peng; Shustov, Andrei R; Hü ttmann, Andreas; Savage, Kerry J.; Yuen, Sam; Zinzani, Pier Luigi; Miao, Harry; Bunn, Veronica; Fenton, Keenan; Fanale, Michelle A.; Puhlmann, Markus; Truemper, Lorenz; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY; E. Couric Cancer Center, University of Virginia, Charlottesville, VA; Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL; Division of Cancer Services, Faculty of Biology,Medicine and Health, University of Manchester, NIHR Biomedical Research Centre, Manchester Academic Health Sciences Centre, Christie Hospital NHS Foundation Trust, Manchester, GBR; MD Anderson Cancer Center/University of Texas, Houston, TX; Stanford Cancer Center, Blood and Marrow Transplant Program, Stanford, CA; Division of Oncology, Washington University School of Medicine in St Louis, St. Louis, MO; Odense University Hospital, Odense, Denmark; CHRU de Lille, Lille cedex, Nord-Pas-de-Calais, France; Institut Catala D'oncologia, L'Hospitalet de Llobregat, Barcelona, Spain; Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Italy; Sam; (Blood, v.136, 2020, pp.3-5)
QUICK MENU
